TY  - GEN
AU  - Pelengaris,Stella
AU  - Khan,Mike
TI  - The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth
SN  - 1744-7631
PY  - 2005///1213
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
KW  - physiology
KW  - Cell Cycle
KW  - Cell Differentiation
KW  - Cell Division
KW  - Coronary Restenosis
KW  - prevention & control
KW  - Diabetes Mellitus
KW  - drug therapy
KW  - Drug Design
KW  - Gene Expression Regulation, Neoplastic
KW  - Genes, myc
KW  - Genetic Therapy
KW  - Glucose
KW  - metabolism
KW  - Growth Substances
KW  - Humans
KW  - Hypoglycemic Agents
KW  - adverse effects
KW  - Insulin
KW  - Insulin Secretion
KW  - Islets of Langerhans
KW  - Mice
KW  - Mice, Transgenic
KW  - Models, Biological
KW  - Neoplasms
KW  - Oligonucleotides, Antisense
KW  - therapeutic use
KW  - Proto-Oncogene Mas
KW  - Proto-Oncogene Proteins c-myc
KW  - antagonists & inhibitors
KW  - RNA, Small Interfering
KW  - Repressor Proteins
KW  - Transcription, Genetic
KW  - Tumor Escape
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1517/14728222.7.5.623
ER  -